A significant advance in cancer research is emerging with the use of nanobodies to reactivate dysfunctional p53. This essential tumor protector protein is frequently lost in various kinds of tumors, leading https://socialwebleads.com/story7494330/mini-antibodies-reactivate-p53-the-new-hope-for-malignant-treatment